HC Wainwright & Co. Initiates Coverage On Aura Biosciences with Buy Rating, Announces Price Target of $21
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has initiated coverage on Aura Biosciences (NASDAQ:AURA) with a Buy rating and a price target of $21.

July 25, 2024 | 11:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has initiated coverage on Aura Biosciences with a Buy rating and a price target of $21.
The initiation of coverage with a Buy rating and a specific price target of $21 by a reputable analyst firm like HC Wainwright & Co. is likely to positively impact the stock price of Aura Biosciences in the short term. This is because such ratings often influence investor sentiment and can lead to increased buying activity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100